{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T12:37:15Z","timestamp":1791549435196,"version":"4.3.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T00:00:00Z","timestamp":1735862400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Chengdu Science and Technology Program","award":["2022-YF05-02153-SN"],"award-info":[{"award-number":["2022-YF05-02153-SN"]}]},{"name":"Sichuan Medical Association Medical research project","award":["S2024070"],"award-info":[{"award-number":["S2024070"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Human Cell"],"DOI":"10.1007\/s13577-024-01168-6","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T10:21:24Z","timestamp":1735899684000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Taxifolin regulates SLC31A1-mediated cuproptosis and tumor progression in hepatocellular carcinoma"],"prefix":"10.1007","volume":"38","author":[{"given":"Jike","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuelian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengshi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3972-5387","authenticated-orcid":false,"given":"Mei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,3]]},"reference":[{"issue":"12","key":"1168_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","volume":"20","author":"AG Singal","year":"2023","unstructured":"Singal AG, Kanwal F, Llovet JM. Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy. Nat Rev Clin Oncol. 2023;20(12):864\u201384. https:\/\/doi.org\/10.1038\/s41571-023-00825-3.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"1168_CR2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.3390\/cancers15020533","volume":"15","author":"C Shen","year":"2023","unstructured":"Shen C, Jiang X, Li M, Luo Y. Hepatitis virus and hepatocellular carcinoma: recent advances. Cancers. 2023;15(2):533. https:\/\/doi.org\/10.3390\/cancers15020533.","journal-title":"Cancers"},{"key":"1168_CR3","doi-asserted-by":"publisher","first-page":"1695802","DOI":"10.1155\/2022\/1695802","volume":"2022","author":"C Wang","year":"2022","unstructured":"Wang C, Liu J, Yan Y, Tan Y. Role of exosomes in chronic liver disease development and their potential clinical applications. J Immunol Res. 2022;2022:1695802. https:\/\/doi.org\/10.1155\/2022\/1695802.","journal-title":"J Immunol Res"},{"issue":"1","key":"1168_CR4","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1186\/s12967-023-04386-y","volume":"21","author":"Y Yang","year":"2023","unstructured":"Yang Y, Xiong L, Li M, Jiang P, Wang J, Li C. Advances in radiotherapy and immunity in hepatocellular carcinoma. J Transl Med. 2023;21(1):526. https:\/\/doi.org\/10.1186\/s12967-023-04386-y.","journal-title":"J Transl Med"},{"issue":"4","key":"1168_CR5","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41575-022-00704-9","volume":"20","author":"C Yang","year":"2023","unstructured":"Yang C, Zhang H, Zhang L, Zhu AX, Bernards R, Qin W, Wang C. Evolving therapeutic landscape of advanced hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2023;20(4):203\u201322. https:\/\/doi.org\/10.1038\/s41575-022-00704-9.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"2","key":"1168_CR6","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.jpha.2020.06.008","volume":"11","author":"FC Stenger Moura","year":"2021","unstructured":"Stenger Moura FC, dos Santos Machado CL, Reisdorfer Paula F, Garcia Couto A, Ricci M, Cechinel-Filho V, Bonomini TJ, Sandjo LP, Bell\u00e9 Bresolin TM. Taxifolin stability: in silico prediction and in vitro degradation with HPLC-UV\/UPLC\u2013ESI-MS monitoring. J Pharm Anal. 2021;11(2):232\u201340. https:\/\/doi.org\/10.1016\/j.jpha.2020.06.008.","journal-title":"J Pharm Anal"},{"issue":"5","key":"1168_CR7","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3390\/nu14051069","volume":"14","author":"W Li","year":"2022","unstructured":"Li W, Zhang L, Xu Q, Yang W, Zhao J, Ren Y, Yu Z, Ma L. Taxifolin alleviates DSS-induced ulcerative colitis by acting on gut microbiome to produce butyric acid. Nutrients. 2022;14(5):1069. https:\/\/doi.org\/10.3390\/nu14051069.","journal-title":"Nutrients"},{"key":"1168_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phytochem.2019.112066","volume":"166","author":"C Sunil","year":"2019","unstructured":"Sunil C, Xu B. An insight into the health-promoting effects of taxifolin (dihydroquercetin). Phytochemistry. 2019;166: 112066. https:\/\/doi.org\/10.1016\/j.phytochem.2019.112066.","journal-title":"Phytochemistry"},{"issue":"3","key":"1168_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1134\/s0006297909030092","volume":"74","author":"YA Vladimirov","year":"2009","unstructured":"Vladimirov YA, Proskurnina EV, Demin EM, Matveeva NS, Lubitskiy OB, Novikov AA, Izmailov DY, Osipov AN, Tikhonov VP, Kagan VE. Dihydroquercetin (taxifolin) and other flavonoids as inhibitors of free radical formation at key stages of apoptosis. Biochemistry. 2009;74(3):301\u20137. https:\/\/doi.org\/10.1134\/s0006297909030092.","journal-title":"Biochemistry"},{"issue":"11","key":"1168_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e22011","volume":"9","author":"Z Lin","year":"2023","unstructured":"Lin Z, Wang J. Taxifolin protects against doxorubicin-induced cardiotoxicity and ferroptosis by adjusting microRNA-200a-mediated Nrf2 signaling pathway. Heliyon. 2023;9(11): e22011. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e22011.","journal-title":"Heliyon"},{"key":"1168_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.155199","volume":"123","author":"L Xu","year":"2024","unstructured":"Xu L, Zhang L, Zhang S, Yang J, Zhu A, Sun J, Kalvakolanu DV, Cong X, Zhang J, Tang J, Guo B. Taxifolin inhibits melanoma proliferation\/migration impeding USP18\/Rac1\/JNK\/\u03b2-catenin oncogenic signaling. Phytomedicine. 2024;123: 155199. https:\/\/doi.org\/10.1016\/j.phymed.2023.155199.","journal-title":"Phytomedicine"},{"issue":"1","key":"1168_CR12","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/s41392-022-01229-y","volume":"7","author":"L Chen","year":"2022","unstructured":"Chen L, Min J, Wang F. Copper homeostasis and cuproptosis in health and disease. Signal Transduct Target Ther. 2022;7(1):378. https:\/\/doi.org\/10.1038\/s41392-022-01229-y.","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"1168_CR13","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s41419-023-05639-w","volume":"14","author":"X Chen","year":"2023","unstructured":"Chen X, Cai Q, Liang R, Zhang D, Liu X, Zhang M, Xiong Y, Xu M, Liu Q, Li P, Yu P, Shi A. Copper homeostasis and copper-induced cell death in the pathogenesis of cardiovascular disease and therapeutic strategies. Cell Death Dis. 2023;14(2):105. https:\/\/doi.org\/10.1038\/s41419-023-05639-w.","journal-title":"Cell Death Dis"},{"key":"1168_CR14","doi-asserted-by":"publisher","first-page":"1229297","DOI":"10.3389\/fphar.2023.1229297","volume":"14","author":"Y Yang","year":"2023","unstructured":"Yang Y, Feng Q, Luan Y, Liu H, Jiao Y, Hao H, Yu B, Luan Y, Ren K. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases. Front Pharmacol. 2023;14:1229297. https:\/\/doi.org\/10.3389\/fphar.2023.1229297.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1168_CR15","doi-asserted-by":"publisher","first-page":"20870","DOI":"10.1038\/s41598-023-47223-4","volume":"13","author":"Y Huang","year":"2023","unstructured":"Huang Y, Gong P, Su L, Zhang M. Cuproptosis-related lncRNA scoring system to predict the clinical outcome and immune landscape in pancreatic adenocarcinoma. Sci Rep. 2023;13(1):20870. https:\/\/doi.org\/10.1038\/s41598-023-47223-4.","journal-title":"Sci Rep"},{"issue":"11","key":"1168_CR16","first-page":"5590","volume":"13","author":"B Quan","year":"2023","unstructured":"Quan B, Liu W, Yao F, Li M, Tang B, Li J, Ren Z, Yin X. LINC02362\/hsa-miR-18a-5p\/FDX1 axis suppresses proliferation and drives cuproptosis and oxaliplatin sensitivity of hepatocellular carcinoma. Am J Cancer Res. 2023;13(11):5590\u2013609.","journal-title":"Am J Cancer Res"},{"issue":"1","key":"1168_CR17","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1038\/s41467-023-42025-8","volume":"14","author":"L Sun","year":"2023","unstructured":"Sun L, Zhang Y, Yang B, Sun S, Zhang P, Luo Z, Feng T, Cui Z, Zhu T, Li Y, Qiu Z, Fan G, Huang C. Lactylation of METTL16 promotes cuproptosis via m(6)A-modification on FDX1 mRNA in gastric cancer. Nat Commun. 2023;14(1):6523. https:\/\/doi.org\/10.1038\/s41467-023-42025-8.","journal-title":"Nat Commun"},{"issue":"12","key":"1168_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110995","volume":"39","author":"DJ Wilcock","year":"2022","unstructured":"Wilcock DJ, Badrock AP, Wong CW, Owen R, Guerin M, Southam AD, Johnston H, Telfer BA, Fullwood P, Watson J, Ferguson H, Ferguson J, Lloyd GR, Jankevics A, Dunn WB, Wellbrock C, Lorigan P, Ceol C, Francavilla C, Smith MP, Hurlstone AFL. Oxidative stress from DGAT1 oncoprotein inhibition in melanoma suppresses tumor growth when ROS defenses are also breached. Cell Rep. 2022;39(12): 110995. https:\/\/doi.org\/10.1016\/j.celrep.2022.110995.","journal-title":"Cell Rep"},{"issue":"1","key":"1168_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12864-015-1298-6","volume":"16","author":"RA Walker","year":"2015","unstructured":"Walker RA, Sharman PA, Miller CM, Lippuner C, Okoniewski M, Eichenberger RM, Ramakrishnan C, Brossier F, Deplazes P, Hehl AB, Smith NC. RNA Seq analysis of the Eimeria tenella gametocyte transcriptome reveals clues about the molecular basis for sexual reproduction and oocyst biogenesis. BMC Genomics. 2015;16(1):94. https:\/\/doi.org\/10.1186\/s12864-015-1298-6.","journal-title":"BMC Genomics"},{"issue":"1","key":"1168_CR20","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1186\/s40001-023-01137-z","volume":"28","author":"G Luo","year":"2023","unstructured":"Luo G, Wang L, Zheng Z, Gao B, Lei C. Cuproptosis-related ferroptosis genes for predicting prognosis in kidney renal clear cell carcinoma. Eur J Med Res. 2023;28(1):176. https:\/\/doi.org\/10.1186\/s40001-023-01137-z.","journal-title":"Eur J Med Res"},{"issue":"1","key":"1168_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12885-023-10678-9","volume":"23","author":"Q Liu","year":"2023","unstructured":"Liu Q, Li R, Wu H, Liang Z. A novel cuproptosis-related gene model predicts outcomes and treatment responses in pancreatic adenocarcinoma. BMC Cancer. 2023;23(1):226. https:\/\/doi.org\/10.1186\/s12885-023-10678-9.","journal-title":"BMC Cancer"},{"key":"1168_CR22","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ejca.2021.11.023","volume":"161","author":"H Rumgay","year":"2022","unstructured":"Rumgay H, Ferlay J, de Martel C, Georges D, Ibrahim AS, Zheng R, Wei W, Lemmens VEPP, Soerjomataram I. Global, regional and national burden of primary liver cancer by subtype. Eur J Cancer. 2022;161:108\u201318. https:\/\/doi.org\/10.1016\/j.ejca.2021.11.023.","journal-title":"Eur J Cancer"},{"key":"1168_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3390\/ijtm3010005","volume":"3","author":"NS Parra","year":"2023","unstructured":"Parra NS, Ross HM, Khan A, Wu M, Goldberg R, Shah L, Mukhtar S, Beiriger J, Gerber A, Halegoua-DeMarzio D. Advancements in the diagnosis of hepatocellular carcinoma. Int J Transl Med. 2023;3:51\u201365. https:\/\/doi.org\/10.3390\/ijtm3010005.","journal-title":"Int J Transl Med"},{"key":"1168_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112004","volume":"142","author":"A Das","year":"2021","unstructured":"Das A, Baidya R, Chakraborty T, Samanta AK, Roy S. Pharmacological basis and new insights of taxifolin: a comprehensive review. Biomed Pharmacother. 2021;142: 112004. https:\/\/doi.org\/10.1016\/j.biopha.2021.112004.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"1168_CR25","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2174\/1567201815666180116090258","volume":"15","author":"MC Alves","year":"2018","unstructured":"Alves MC, de Almeida PA, Polonini HC, Bhering CAP, de Ferreira OA, Brandao MAF, Raposo NRB. Taxifolin: evaluation through ex vivo permeations on human skin and porcine vaginal mucosa. Curr Drug Deliv. 2018;15(8):1123\u201334. https:\/\/doi.org\/10.2174\/1567201815666180116090258.","journal-title":"Curr Drug Deliv"},{"key":"1168_CR26","doi-asserted-by":"publisher","first-page":"1173855","DOI":"10.3389\/fphar.2023.1173855","volume":"14","author":"Y Liu","year":"2023","unstructured":"Liu Y, Shi X, Tian Y, Zhai S, Liu Y, Xiong Z, Chu S. An insight into novel therapeutic potentials of taxifolin. Front Pharmacol. 2023;14:1173855. https:\/\/doi.org\/10.3389\/fphar.2023.1173855.","journal-title":"Front Pharmacol"},{"issue":"9","key":"1168_CR27","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.3390\/molecules21091209","volume":"21","author":"P Yang","year":"2016","unstructured":"Yang P, Xu F, Li HF, Wang Y, Li FC, Shang MY, Liu GX, Wang X, Cai SQ. Detection of 191 taxifolin metabolites and their distribution in rats using HPLC-ESI-IT-TOF-MS(n). Molecules. 2016;21(9):1209. https:\/\/doi.org\/10.3390\/molecules21091209.","journal-title":"Molecules"},{"key":"1168_CR28","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s40610-021-00146-3","volume":"7","author":"Q Zia","year":"2021","unstructured":"Zia Q, Azhar A, Hassan N, Jain P, Singh M, Mirza MA, Ali A, Parveen S, Hasan S, Alothaim AS, Jamal A. Cell death: a molecular perspective. Curr Mol Bio Rep. 2021;7:41\u201366. https:\/\/doi.org\/10.1007\/s40610-021-00146-3.","journal-title":"Curr Mol Bio Rep"},{"key":"1168_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00689-6","author":"J Yuan","year":"2023","unstructured":"Yuan J, Ofengeim D. A guide to cell death pathways. Nat Rev Mol Cell Biol. 2023. https:\/\/doi.org\/10.1038\/s41580-023-00689-6.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"1168_CR30","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12964-021-00799-8","volume":"19","author":"J Cui","year":"2021","unstructured":"Cui J, Zhao S, Li Y, Zhang D, Wang B, Xie J, Wang J. Regulated cell death: discovery, features and implications for neurodegenerative diseases. Cell Commun Signal. 2021;19(1):120. https:\/\/doi.org\/10.1186\/s12964-021-00799-8.","journal-title":"Cell Commun Signal"},{"issue":"1","key":"1168_CR31","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41420-023-01749-8","volume":"9","author":"JL Lu","year":"2023","unstructured":"Lu JL, Yu CX, Song LJ. Programmed cell death in hepatic fibrosis: current and perspectives. Cell Death Discov. 2023;9(1):449. https:\/\/doi.org\/10.1038\/s41420-023-01749-8.","journal-title":"Cell Death Discov"},{"issue":"1","key":"1168_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12943-022-01508-w","volume":"21","author":"L Liu","year":"2022","unstructured":"Liu L, Li H, Hu D, Wang Y, Shao W, Zhong J, Yang S, Liu J, Zhang J. Insights into N6-methyladenosine and programmed cell death in cancer. Mol Cancer. 2022;21(1):32. https:\/\/doi.org\/10.1186\/s12943-022-01508-w.","journal-title":"Mol Cancer"},{"key":"1168_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2022.965064","volume":"9","author":"H Ma","year":"2022","unstructured":"Ma H, Dong Y, Chu Y, Guo Y, Li L. The mechanisms of ferroptosis and its role in alzheimer\u2019s disease. Front Mol Biosci. 2022;9: 965064. https:\/\/doi.org\/10.3389\/fmolb.2022.965064.","journal-title":"Front Mol Biosci"},{"key":"1168_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04815-y","author":"Q Li","year":"2023","unstructured":"Li Q, Wang T, Zhou Y, Shi J. Cuproptosis in lung cancer: mechanisms and therapeutic potential. Mol Cell Biochem. 2023. https:\/\/doi.org\/10.1007\/s11010-023-04815-y.","journal-title":"Mol Cell Biochem"},{"issue":"6586","key":"1168_CR35","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B, Dreishpoon M, Verma A, Abdusamad M, Rossen J, Joesch-Cohen L, Humeidi R, Spangler RD, Eaton JK, Frenkel E, Kocak M, Corsello SM, Lutsenko S, Kanarek N, Santagata S, Golub TR. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 2022;375(6586):1254\u201361. https:\/\/doi.org\/10.1126\/science.abf0529.","journal-title":"Science"},{"key":"1168_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmolb.2021.711227","volume":"8","author":"LM Ruiz","year":"2021","unstructured":"Ruiz LM, Libedinsky A, Elorza AA. Role of copper on mitochondrial function and metabolism. Front Mol Biosci. 2021;8: 711227. https:\/\/doi.org\/10.3389\/fmolb.2021.711227.","journal-title":"Front Mol Biosci"},{"key":"1168_CR37","doi-asserted-by":"publisher","first-page":"1288504","DOI":"10.3389\/fonc.2023.1288504","volume":"13","author":"M Wang","year":"2023","unstructured":"Wang M, Zheng L, Ma S, Lin R, Li J, Yang S. Cuproptosis: emerging biomarkers and potential therapeutics in cancers. Front Oncol. 2023;13:1288504. https:\/\/doi.org\/10.3389\/fonc.2023.1288504.","journal-title":"Front Oncol"},{"issue":"1","key":"1168_CR38","doi-asserted-by":"publisher","first-page":"17790","DOI":"10.1038\/s41598-023-44681-8","volume":"13","author":"Y Qi","year":"2023","unstructured":"Qi Y, Yao Q, Li X, Li X, Zhang W, Qu P. Cuproptosis-related gene SLC31A1: prognosis values and potential biological functions in cancer. Sci Rep. 2023;13(1):17790. https:\/\/doi.org\/10.1038\/s41598-023-44681-8.","journal-title":"Sci Rep"},{"issue":"1","key":"1168_CR39","doi-asserted-by":"publisher","first-page":"18390","DOI":"10.1038\/s41598-023-45761-5","volume":"13","author":"JH Wu","year":"2023","unstructured":"Wu JH, Cheng TC, Zhu B, Gao HY, Zheng L, Chen WX. Identification of cuproptosis-related gene SLC31A1 and upstream LncRNA-miRNA regulatory axis in breast cancer. Sci Rep. 2023;13(1):18390. https:\/\/doi.org\/10.1038\/s41598-023-45761-5.","journal-title":"Sci Rep"},{"issue":"2","key":"1168_CR40","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/ijms24021667","volume":"24","author":"S Huo","year":"2023","unstructured":"Huo S, Wang Q, Shi W, Peng L, Jiang Y, Zhu M, Guo J, Peng D, Wang M, Men L, Huang B, Lv J, Lin L. ATF3\/SPI1\/SLC31A1 signaling promotes cuproptosis induced by advanced glycosylation end products in diabetic myocardial injury. Int J Mol Sci. 2023;24(2):1667. https:\/\/doi.org\/10.3390\/ijms24021667.","journal-title":"Int J Mol Sci"},{"key":"1168_CR41","doi-asserted-by":"publisher","first-page":"1194046","DOI":"10.3389\/fmed.2023.1194046","volume":"10","author":"W Lian","year":"2023","unstructured":"Lian W, Yang P, Li L, Chen D, Wang C. A ceRNA network-mediated over-expression of cuproptosis-related gene SLC31A1 correlates with poor prognosis and positive immune infiltration in breast cancer. Front Med. 2023;10:1194046. https:\/\/doi.org\/10.3389\/fmed.2023.1194046.","journal-title":"Front Med"},{"issue":"1","key":"1168_CR42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s12885-022-10461-2","volume":"23","author":"C Ke","year":"2023","unstructured":"Ke C, Dai S, Xu F, Yuan J, Fan S, Chen Y, Yang L, Li Y. Cuproptosis regulatory genes greatly contribute to clinical assessments of hepatocellular carcinoma. BMC Cancer. 2023;23(1):25. https:\/\/doi.org\/10.1186\/s12885-022-10461-2.","journal-title":"BMC Cancer"},{"key":"1168_CR43","doi-asserted-by":"publisher","first-page":"1123231","DOI":"10.3389\/fimmu.2023.1123231","volume":"14","author":"X Wang","year":"2023","unstructured":"Wang X, Chen D, Shi Y, Luo J, Zhang Y, Yuan X, Zhang C, Shu H, Yu W, Tian J. Copper and cuproptosis-related genes in hepatocellular carcinoma: therapeutic biomarkers targeting tumor immune microenvironment and immune checkpoints. Front Immunol. 2023;14:1123231. https:\/\/doi.org\/10.3389\/fimmu.2023.1123231.","journal-title":"Front Immunol"}],"container-title":["Human Cell"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13577-024-01168-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13577-024-01168-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:37:27Z","timestamp":1741311447000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13577-024-01168-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,3]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["1168"],"URL":"https:\/\/doi.org\/10.1007\/s13577-024-01168-6","relation":{},"ISSN":["1749-0774"],"issn-type":[{"value":"1749-0774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,3]]},"assertion":[{"value":"2 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Chengdu Public Health Clinical Center (Approval No: YJ-K2024-13-01, Chengdu, China; time of ethics approval: 2024-01-13).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"37"}}